Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma.
Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma.
复制标题
DOI:
10.1080/21655979.2021.1985818
复制
发表时间:
2021-12
期刊:
影响因子:
4.9
通讯作者:
Pang Q
中科院分区:
文献类型:
--
作者:
Feng S;Liu H;Dong X;Du P;Guo H;Pang Q
Abnormal levels of autophagy have been implicated in the pathogenesis of multiple diseases, including cancer. However, little is known about the role of autophagy-related genes (ARGs) in low-grade gliomas (LGG). Accordingly, the aims of this study were to assess the prognostic values of ARGs and to establish a genetic signature for LGG prognosis. Expression profile data from patients with and without primary LGG were obtained from The Cancer Genome Atlas (TCGA) and Genome Tissue Expression databases, respectively, and consensus clustering was used to identify clusters of patients with distinct prognoses. Nineteen differentially expressed ARGs were selected with threshold values of FDR < 0.05 and |log2 fold change (FC)| ≥ 2, and functional analysis revealed that these genes were associated with autophagy processes as expected. An autophagy-related signature was established using a Cox regression model of six ARGs that separated patients from TCGA training cohort into high- and low-risk groups. Univariate and multivariate Cox regression analysis indicated that the signature-based risk score was an independent prognostic factor. The signature was successfully validated using the TCGA testing, TCGA entire, and Chinese Glioma Genome Atlas cohorts. Stratified analyses demonstrated that the signature was associated with clinical features and prognosis, and gene set enrichment analysis revealed that autophagy- and cancer-related pathways were more enriched in high-risk patients than in low-risk patients. The prognostic value and expression of the six signature-related genes were also investigated. Thus, the present study constructed and validated an autophagy-related prognostic signature that could optimize individualized survival prediction in LGG patients.
登录
查看更多内容
影响因子:
11.2
作者:
Bartholomeusz C;Rosen D;Wei C;Kazansky A;Yamasaki F;Takahashi T;Itamochi H;Kondo S;Liu J;Ueno NT
通讯作者:
Ueno NT
影响因子:
13.3
作者:
Kim, Sun-Yong;Kim, Hyo Jeong;Kim, Chul-Ho
通讯作者:
Kim, Chul-Ho
影响因子:
3.9
作者:
Brigliadori, Giovanni;Foca, Flavia;Faedi, Marina
通讯作者:
Faedi, Marina
DOI:
10.1016/j.bbadis.2021.166262
发表时间:
2021-12-01
期刊:
Biochimica et biophysica acta. Molecular basis of disease
影响因子:
--
作者:
Ariosa AR;Lahiri V;Lei Y;Yang Y;Yin Z;Zhang Z;Klionsky DJ
通讯作者:
Klionsky DJ
影响因子:
64.5
作者:
Ceccarelli M;Barthel FP;Malta TM;Sabedot TS;Salama SR;Murray BA;Morozova O;Newton Y;Radenbaugh A;Pagnotta SM;Anjum S;Wang J;Manyam G;Zoppoli P;Ling S;Rao AA;Grifford M;Cherniack AD;Zhang H;Poisson L;Carlotti CG Jr;Tirapelli DP;Rao A;Mikkelsen T;Lau CC;Yung WK;Rabadan R;Huse J;Brat DJ;Lehman NL;Barnholtz-Sloan JS;Zheng S;Hess K;Rao G;Meyerson M;Beroukhim R;Cooper L;Akbani R;Wrensch M;Haussler D;Aldape KD;Laird PW;Gutmann DH;TCGA Research Network;Noushmehr H;Iavarone A;Verhaak RG
通讯作者:
Verhaak RG